Lazard Next Gen Technologies ETFTEKY

TEKY launched as the Lazard Next Gen Technologies ETF, trading under ticker TEKY on Nasdaq, where the exchange lists it like any other equity product-no fanfare, just a ticker in the queue. The fund’s mandate is straightforward: track the Lazard Next Gen Technologies Index, a rules-based basket meant to capture companies engaged in emerging technologies, from AI infrastructure to advanced materials and biotech tools. The Nasdaq listing confirms the instrument exists, but the page offers no insight into what’s inside or how it’s performing; it merely confirms TEKY is a listed ETF with a ticker and a price. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/teky)

The wrapper’s job is to sell a theme-“Next Gen Technologies”-while the basket does the real work and the 0.60% expense ratio does the real talking. The fund doesn’t manufacture the tech; it buys slices of companies the index committee deems relevant, then charges investors for the convenience of owning those slices through its structure. The marketing promises exposure to cutting-edge innovation, but the fine print reminds you that innovation doesn’t pay the fund’s bills; the fee does. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/teky)

What TEKY actually holds is buried in SEC EDGAR filings, where the fund’s holdings and weightings appear in a dense document designed for compliance, not clarity. The filing confirms the fund exists, provides the index methodology, and lists the holdings, but offers no guarantees that the basket’s contents will relative strength or even keep pace with the hype. The issuer’s marketing can call anything “Next Gen,” but the SEC filing proves it’s just a list of tickers and weights. (source: SEC EDGAR fund search for TEKY, https://www.sec.gov/edgar/search/#/q=TEKY)

The FINRA Fund Analyzer tool confirms the fund’s 0.60% gross expense ratio and provides a standardised view of costs, but it doesn’t reveal performance, holdings, or index composition-only the toll the wrapper extracts. The tool treats TEKY like any other ETF, applying the same cost lens without endorsing the theme. There’s no crystal ball here, only a fee schedule and a reminder that the wrapper’s job is to charge, not to predict. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)

What changed today: nothing in the evidence suggests a material update to TEKY’s holdings, fee, or mandate. The Nasdaq listing page, SEC filings, and FINRA tool all point to the same static facts: TEKY is an ETF tracking a Lazard index, charging 0.60% per year, and trading under ticker TEKY on Nasdaq. The wrapper’s pitch remains unchanged; the basket and fee remain unchanged. Without a new filing, earnings release, or index rebalancing notice, TEKY’s story is a loop of “here we are” and “here’s what it costs.” (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/teky; SEC EDGAR, https://www.sec.gov/edgar/search/#/q=TEKY; FINRA, https://tools.finra.org/fund_analyzer/)

What remains unproven: the fund’s performance against its mandate, the accuracy of the index’s “Next Gen” selection process, and whether the 0.60% fee is justified by the returns. The evidence supplies the wrapper’s toll and the index’s existence, but not its efficacy. Until a filing, earnings update, or independent benchmarking proves otherwise, TEKY’s story is the fee, the list, and the lack of surprises. (source: Nasdaq, SEC EDGAR, FINRA)

What would deepen the file: a Lazard index methodology document with clear rules for inclusion and rebalancing, a quarterly holdings update from the issuer, or a third-party performance comparison against a peer ETF tracking a similar but distinct “Next Gen” index. Without these, TEKY’s narrative stays stuck in the present tense of “it exists, it costs, it trades.” (source: Nasdaq, SEC EDGAR, FINRA)